Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group. Canonico M, et al. Among authors: trillot n. Circulation. 2007 Feb 20;115(7):840-5. doi: 10.1161/CIRCULATIONAHA.106.642280. Circulation. 2007. PMID: 17309934 Clinical Trial.
Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.
Canonico M, Oger E, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; EStrogen and THromboEmbolism Risk (ESTHER) Study Group. Canonico M, et al. Among authors: trillot n. J Thromb Haemost. 2006 Jun;4(6):1259-65. doi: 10.1111/j.1538-7836.2006.01933.x. J Thromb Haemost. 2006. PMID: 16706969 Free article.
Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, Alhenc-Gelas M, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group. Straczek C, et al. Among authors: trillot n. Circulation. 2005 Nov 29;112(22):3495-500. doi: 10.1161/CIRCULATIONAHA.105.565556. Epub 2005 Nov 21. Circulation. 2005. PMID: 16301339
[When to test for thrombophilia?].
Pernod G, Biron-Andreani C, Morange PE, Boehlen F, Constans J, Couturaud F, Drouet L, Jude B, Lecompte T, Le Gal G, Trillot N, Wahl D. Pernod G, et al. Among authors: trillot n. Rev Prat. 2009 Oct 20;59(8):1044-6. Rev Prat. 2009. PMID: 19894436 French. No abstract available.
Recommendations on testing for thrombophilia in venous thromboembolic disease: a French consensus guideline.
Pernod G, Biron-Andreani C, Morange PE, Boehlen F, Constans J, Couturaud F, Drouet L, Jude B, Lecompte T, Le Gal G, Trillot N, Wahl D; French group on haemostasis and thrombosis; French Society of vascular medicine. Pernod G, et al. Among authors: trillot n. J Mal Vasc. 2009 May;34(3):156-203. doi: 10.1016/j.jmv.2009.02.005. J Mal Vasc. 2009. PMID: 19645086 English, French. No abstract available.
Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia.
Casini A, von Mackensen S, Santoro C, Djambas Khayat C, Belhani M, Ross C, Dorgalaleh A, Naz A, Ünal E, Abdelwahab M, Lozeron ED, Trillot N, Susen S, Peyvandi F, de Moerloose P; QualyAfib Study Group. Casini A, et al. Among authors: trillot n. Blood. 2021 Jun 3;137(22):3127-3136. doi: 10.1182/blood.2020009472. Blood. 2021. PMID: 33512441 Free article. Clinical Trial.
43 results